Skip to main content

Vaccine: X

  • ISSN: 2590-1362

Editor-In-Chief: Poland

Next planned ship date: June 4, 2024

  • 5 Year impact factor: 3.6
  • Impact factor: 3.8

Vaccine: X is the open access companion journal of Vaccine and has the same aims and scope. The journal offers authors who want to publish in a gold open access journal the oppo… Read more

Subscription options

Next planned ship date:
June 4, 2024

Institutional subscription on ScienceDirect

Request a sales quote


Vaccine: X is the open access companion journal of Vaccine and has the same aims and scope. The journal offers authors who want to publish in a gold open access journal the opportunity to make their work immediately and permanently accessible.

Vaccine: X publishes high quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. Relevant, sound scientific work in all aspects of vaccine research that yielded negative results and would otherwise not be published is also welcome. Besides original research, we invite authors to submit basic science and clinical reviews, methodological articles, case reports, opinion and commentary pieces, visual pieces, and letters.
Authors are required to consult the Guide for Authors as the submission guidelines are dynamic and therefore subject to change.